Next Biomedical Co.,Ltd.

KOSDAQ:A389650 Stock Report

Market Cap: ₩370.6b

Next BiomedicalLtd Past Earnings Performance

Past criteria checks 2/6

Next BiomedicalLtd has been growing earnings at an average annual rate of 71.1%, while the Medical Equipment industry saw earnings growing at 20.4% annually. Revenues have been growing at an average rate of 89.6% per year. Next BiomedicalLtd's return on equity is 6.2%, and it has net margins of 25.5%.

Key information

71.14%

Earnings growth rate

79.99%

EPS growth rate

Medical Equipment Industry Growth22.66%
Revenue growth rate89.63%
Return on equity6.17%
Net Margin25.53%
Last Earnings Update31 Mar 2025

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Next BiomedicalLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A389650 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2510,9452,7942,9917,352
31 Dec 249,5432,8602,6106,622
30 Sep 248,735-1412,3866,495
31 Mar 245,772-7,3862,6035,185
31 Dec 234,882-7,5222,4074,783
31 Dec 222,795-5,7322,2463,579
31 Dec 212,267-16,6452,8663,245
31 Dec 202,261-24,4771,9942,720
31 Dec 19801-3,7741,5331,601
31 Dec 1881-2,315873525

Quality Earnings: A389650 has a high level of non-cash earnings.

Growing Profit Margin: A389650 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A389650 has become profitable over the past 5 years, growing earnings by 71.1% per year.

Accelerating Growth: A389650 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: A389650 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-10.9%).


Return on Equity

High ROE: A389650's Return on Equity (6.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/08 15:06
End of Day Share Price 2025/07/08 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Next Biomedical Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.